Oxford Talks
Toggle navigation
Help
Login
Development of AZD5363, an inhibitor of AKT with activity in tumours containing mutations in the P13K-AKT pathway
Abstract not yet added
Date
: 2 November 2015, 11:00
Venue
:
Old Road Campus Research Building
Headington OX3 7DQ
See location on maps.ox
Details
: 71A, B and C
Speaker
:
Dr Barry Davis ( AstraZeneca)
Organising department
:
Department of Oncology
Organiser
:
Linda Nemerofksy-Birks (University of Oxford)
Host
:
Anderson Ryan (University of Oxford )
Part of
:
Department of Oncology
Booking required?
: Not required
Audience
: Members of the University only
Editor: Amanda Chapman